Original Query: ALL
Previous Study | Return to List | Next Study

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00881387
Recruitment Status : Withdrawn
First Posted : April 15, 2009
Last Update Posted : December 15, 2016
Information provided by (Responsible Party):
University of Miami

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : October 2012
  Study Completion Date : October 2012